Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease-Reference-Cited by-同舟云学术

Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease

Published:2011-07 Issue:1 Volume:53 Page:26-33
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Zahm Adam M,Thayu Meena,Hand Nicholas J,Horner Amber,Leonard Mary B,Friedman Joshua R

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference71 articles.

1. Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification;Dotan;Exp Rev Gastroenterol Hepatol,2007

2. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease;Koutroubakis;Am J Gastroenterol,2001

3. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease;Peeters;Am J Gastroenterol,2001

4. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role;Quinton;Gut,1998

5. What is the role of serological markers in IBD? Pediatric and adult data;Dubinsky;Dig Dis,2009

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies;Experimental Cell Research;2024-10

2. Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation;Gut Microbes;2024-09-03

3. Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review;International Journal of Molecular Sciences;2024-02-08

4. MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization;Biomedicines;2024-01-07

5. Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing;Brain Communications;2024